You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune therapy pre-treated

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • increasing total fiber intake
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Apr 6, 2023

Breast Cancer Trial in New York (Cryoablation, Ipilimumab, Nivolumab)

Active, not recruiting
  • Breast Cancer
  • Cryoablation
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 1, 2022

Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)

Recruiting
  • Oligorecurrent and Oligoprogressive Prostate Cancer Patients
  • Radiotherapy
  • +2 more
  • Rozzano, Milano, Italy
    Humanitas Research Hospital
May 3, 2022

Previously Treated Primary Immune Thrombocytopenia Trial in China (rhTPO, Eltrombopag)

Recruiting
  • Previously Treated Primary Immune Thrombocytopenia
  • Guangzhou, Guangdong, China
  • +15 more
Jan 24, 2023

Lung Cancer Trial in Wuhan (Pirfenidone)

Recruiting
  • Lung Cancer
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Mar 24, 2023

High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1

Suspended
  • NSCLC Stage IV
  • NSCLC, Stage IIIC
  • Primary Immune Response (PIR) test by Biodesix, Inc.
  • San Carlos, California
  • +1 more
Jan 26, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Immune Environment in Response to Therapy in Breast Cancer

Recruiting
  • Breast Cancer
  • +3 more
  • Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
Sep 15, 2022

Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Recruiting
  • Lung Neoplasms
  • +3 more
  • Observation
  • Shanghai, China
    Shanghai Chest Hospital
Mar 14, 2022

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Testing ofEducational Tool for Melanoma and Pre-Existing

Recruiting
  • Ankylosing Spondylitis
  • +12 more
  • Best Practice
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

After Vaccination Against COVID-19 in Patients Treated With

Recruiting
  • Kidney Failure, Chronic
  • +3 more
  • Immune response
  • Solicited common and expected adverse reactions shortly following vaccination (reactogenicity), use of antipyretic or pain medications and unsolicited adverse events and serious adverse events
  • Gdansk, Pomorskie, Poland
  • +3 more
Feb 3, 2022

Pre-menopausal Metastatic Breast Cancer Patients Treated With

Completed
  • Metastatic Breast Cancer
  • Palbociclib + aromatase inhibitor
  • Aromatase inhibitor
  • New York, New York
    Pfizer New York
Feb 25, 2022

A Study of Immunotherapy Treatment in People With Sarcoma

Enrolling by invitation
  • Sarcoma
    • Basking Ridge, New Jersey
    • +6 more
    Oct 27, 2023

    NSCLC Metastatic Trial (bevacizumab plus nab-paclitaxel and platinum)

    Not yet recruiting
    • Non-small Cell Lung Cancer Metastatic
    • bevacizumab plus nab-paclitaxel and platinum
    • (no location specified)
    Jun 2, 2022

    Metastatic Melanoma Trial in Pierre-Bénite (Blood and biopsy sampling)

    Completed
    • Metastatic Melanoma
    • Blood and biopsy sampling
    • Pierre-Bénite, France
      Service de Dermatologie, Centre Hospitalier Lyon Sud (HCL)
    Dec 23, 2021

    ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1

    Not yet recruiting
    • ST Elevation Myocardial Infarction
    • Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
    • Geneva, Switzerland
      Geneva University Hospitals
    Mar 25, 2023

    Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

    Active, not recruiting
    • Hydronephrosis
    • +18 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

    Recruiting
    • Breast Cancer
    • Birmingham, Alabama
    • +3 more
    Apr 15, 2022

    Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Seattle (biological,

    Terminated
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • Durvalumab
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 23, 2022

    Acromegaly Trial in Santa Monica (lanreotide)

    Terminated
    Has Results
    • Acromegaly
    • Santa Monica, California
      Brain Tumor Center and Pituitary Disorders Program, John Wayne C
    Sep 2, 2021

    Breast Cancer Trial in London (Eribulin)

    Terminated
    Has Results
    • Breast Cancer
    • London, United Kingdom
      Charing Cross Hopsital
    Jan 18, 2021

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in Houston (Nivolumab)

    Not yet recruiting
    • Metastatic Malignant Solid Neoplasm
    • Unresectable Solid Neoplasm
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 1, 2021

    SNP rs2910164 in Patients Treated With Immune Checkpoint

    Completed
    • Cancer
      • (no location specified)
      Aug 18, 2020